SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-434971
Filing Date
2014-12-05
Accepted
2014-12-05 17:01:57
Documents
9
Period of Report
2014-12-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d826386d8k.htm 8-K 17545
2 EX-23.1 d826386dex231.htm EX-23.1 1419
3 EX-99.1 d826386dex991.htm EX-99.1 2269999
  Complete submission text file 0001193125-14-434971.txt   20391545

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT act-20131231.xml EX-101.INS 3445444
5 XBRL TAXONOMY EXTENSION SCHEMA act-20131231.xsd EX-101.SCH 178159
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE act-20131231_cal.xml EX-101.CAL 201588
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE act-20131231_def.xml EX-101.DEF 691623
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE act-20131231_lab.xml EX-101.LAB 1267166
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE act-20131231_pre.xml EX-101.PRE 1013772
Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Actavis plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55075 | Film No.: 141270227
SIC: 2834 Pharmaceutical Preparations